Mark J. Ratain to Thyroid Neoplasms
This is a "connection" page, showing publications Mark J. Ratain has written about Thyroid Neoplasms.
Connection Strength
0.018
-
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. J Clin Oncol. 2011 Jul 01; 29(19):2660-6.
Score: 0.018
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.